Profile
Yosemite is a venture capital firm based in San Francisco, founded by Reed Jobs in 2015. The firm is focused primarily on oncology, investing in biotechnology and healthcare innovations aimed at making cancer non-lethal. The team includes notable members such as Matt Bettonville and Dan McHugh, working alongside Reed Jobs. Yosemite is distinguished by its targeted approach to investing in cancer-fighting technologies and its strong links to eminent research institutions and philanthropic foundations.
The firm invests predominantly in biotech and healthcare sectors, specifically targeting oncology-related innovations. Alongside their newly closed Oncology Fund II at $350 million, Yosemite's historical LPs include influential entities like John Doerr, Emerson Collective, Memorial Sloan Kettering Cancer Center, The Rockefeller University, MIT, and Amgen.
Yosemite's noted portfolio companies are focused on groundbreaking oncology and biotech innovations. With strategic collaborations and investments, Yosemite places itself as a dedicated player in the venture capital landscape focused on health innovation.
Industry
Yosemite Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Second Fund
|
Venture Capital (VC)
|
Biotechnology
Healthcare Services
Medical Devices
Pharmaceuticals
MedTech
Life Sciences
HealthTech
|
Seed
Late Stage (Series C+)
|
North America
|
$10-50 m
|
$350 M
|
November 2026
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.